About Prism Diagnostics Private Limited
Data last updated: 23 July 2025
Prism Diagnostics Private Limited was a private limited company based in Thane, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 12 June 1998.
Registered with ROC Mumbai under CIN U85195MH1998PTC115329.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Narendra Dolatlal Shah and Pratap Ramniklal Chandarana.
Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: 7/8 Shiv Shakti Laghu Uduog Sankul Nashik – Mumbai Road Asangaon, Thane, Maharashtra, India – 400601.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.49 Lakh, a decline of 98% compared to the previous year.
As per MCA filings, the company had satisfied charges of ₹54.85 Lakh on record.
The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk. The last known website on record is prismdiag.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address7/8 Shiv Shakti Laghu Uduog Sankul Nashik – Mumbai Road Asangaon, Thane, Maharashtra, India – 400601
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Prism Diagnostics Private Limited
Prism Diagnostics Private Limited has one previous CIN (Corporate Identification Number): U99999MH1998PTC115329. The current CIN is U85195MH1998PTC115329, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195MH1998PTC115329 | Current |
| U99999MH1998PTC115329 | Previous |
Auditor Details of Prism Diagnostics Private Limited
Prism Diagnostics Private Limited is audited by GAJARIA SHAH AND ASSOCIATES for the financial year 2018. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GAJARIA SHAH AND ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Prism Diagnostics Private Limited
Prism Diagnostics Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Narendra Dolatlal Shah
Also directs:
Velon Pharmacal Private Limited
|
Director | 12 Jun 1998 | 28 Years 1 Months | As last reported |
|
Pratap Ramniklal Chandarana
Also directs:
Pooja Diagnostic Laboratory Llp, Ravi Imaging Private Limited, Pooja Diagnostic Centre Private Limited and 1 more
|
Director | 15 Feb 2001 | 25 Years 4 Months | As last reported |
| Nitin Shreekrishna Dalvi | Director | 12 Jun 1998 | 28 Years 1 Months | As last reported |
Financials of Prism Diagnostics Private Limited FY 2023 filings available
Prism Diagnostics Private Limited reported revenue of ₹1.49 Lakh (down 98% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Prism Diagnostics Private Limited
As of FY 2018, Prism Diagnostics Private Limited's shareholding pattern shows 49.80% by promoters, 50.20% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Prism Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2006 | The North Canara G.S.B. Co.Op Bank Ltd. | ₹9.35 Lakh | Satisfied |
| 02 Feb 2005 | The North Kanara Gsb; Co-Op Bank Ltd | ₹5 Lakh | Satisfied |
| 17 May 2004 | The North Kanara Gsb; Co-Op Bank Ltd | ₹5 Lakh | Satisfied |
| 22 Jan 2004 | The North Kanara Gsb; Co-Op Bank Ltd | ₹5 Lakh | Satisfied |
| 25 Jul 2003 | The North Kanara Gsb; Co-Op Bank Ltd | ₹5 Lakh | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Prism Diagnostics Private Limited
View historical data on people associated with Prism Diagnostics Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Prism Diagnostics Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Prism Diagnostics Private Limited
GSTIN & GST Filing Data of Prism Diagnostics Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Prism Diagnostics Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Prism Diagnostics Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Prism Diagnostics Private Limited
MSME Payment Delays by Prism Diagnostics Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Prism Diagnostics Private Limited
Subsidiaries & Group Companies of Prism Diagnostics Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Prism Diagnostics Private Limited with ownership details.
MCA Filings & Documents of Prism Diagnostics Private Limited
MCA Filings & Documents of Prism Diagnostics Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Prism Diagnostics Private Limited
Frequently Asked Questions about Prism Diagnostics Private Limited
Prism Diagnostics Private Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Prism Diagnostics Private Limited is a struck-off private limited company in the healthcare sector based in Thane, Maharashtra, India. It was incorporated on 12 June 1998 and is registered under CIN U85195MH1998PTC115329. The company has been struck off by the Registrar of Companies and is no longer operational.
The current directors of Prism Diagnostics Private Limited are:
The CIN (Corporate Identification Number) of Prism Diagnostics Private Limited is U85195MH1998PTC115329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Prism Diagnostics Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company was active in this sector before being struck off.
The company has its registered office at 78 Shiv Shakti Laghu Uduog Sankul Nashik – Mumbai Road Asangaon, Thane, Maharashtra, India – 400601.